On Monday, Shares of InvenSense Inc (NYSE:INVN), lost -1.94% to $10.11.
InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics. The company delivers intelligent sensor system on chip (SoC) for motion and sound in consumer electronic devices, such as smartphones, tablets, wearables, console and portable video gaming devices, digital television and set-top box remote controls, fitness accessories, sports equipment, digital still cameras, automobiles, ultra-books, laptops, hearing aids, stabilization systems, tools, navigation devices, remote controlled toys, and other household consumer and industrial devices.
InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics. The company delivers intelligent sensor system on chip (SoC) for motion and sound in consumer electronic devices, such as smartphones, tablets, wearables, console and portable video gaming devices, digital television and set-top box remote controls, fitness accessories, sports equipment, digital still cameras, automobiles, ultra-books, laptops, hearing aids, stabilization systems, tools, navigation devices, remote controlled toys, and other household consumer and industrial devices.
Shares of UBS Group AG (USA) (NYSE:UBS), declined -0.20% to $19.75, during its last trading session.
UBS Group AG, declared that it does not intend to issue any new notes in 38 of its outstanding ETRACS ETNs, which are listed in Table I below and form part of a series of UBS AG debt securities designated as “Medium-Term Notes, Series A” (the “Series A ETRACS ETNs”). These Series A ETRACS ETNs will continue to trade on the NYSE Arca. UBS AG anticipates that its associate UBS Securities LLC may continue to sell these Series A ETRACS ETNs that UBS AG has formerly issued or that UBS Securities LLC may acquire in the future. As described in the table below for each Series A ETRACS ETN, this comprises outstanding Series A ETRACS ETNs formerly issued by UBS AG that UBS Securities LLC may repurchase from the public from time to time in addition to Series A ETRACS ETNs issued by UBS AG preceding to the date of this declarement and not yet sold to the public. The maximum number of each Series A ETRACS ETN that could be outstanding at any time is set forth in the last column of Table I below.
This declarement does not affect the terms of the outstanding Series A ETRACS ETNs identified below, counting the right of noteholders to require UBS AG to redeem their notes on the terms, and at the redemption price, set forth in the applicable prospectus supplement (or product supplement and pricing supplement) and the right of UBS AG to call the notes at the prices and under the circumstances set forth in the applicable prospectus supplement (or product supplement and pricing supplement).
UBS Group AG, together with its auxiliaries, provides wealth administration, retail and corporate, asset administration, and investment banking products and services worldwide. The company’s Wealth Administration division provides financial services to wealthy private clients.
Finally, Eros International Plc (NYSE:EROS), ended its last trade with 4.65% gain, and closed at $32.18.
Eros International, declared the formal agenda for its inaugural investor day on Tuesday, October 13, 2015 in New York City at the Trump SoHo New York. Led by Executive Chairman, Kishore Lulla and Group Chief Executive Officer, Jyoti Deshpande, the live event will commence at 1:30 PM EDT with formal presentations from several members of the senior administration team, followed by a cocktail reception.
Eros International PLC, together with its auxiliaries, co-produces, acquires, and distributes Indian language films in various formats worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.